Vanda Pharmaceuticals to Present at the Canaccord Genuity Annual Growth Conference

Presentation will be Webcast Live and Archived on Vanda's Website

Aug 10, 2015, 07:00 ET from Vanda Pharmaceuticals Inc.

WASHINGTON, Aug. 10, 2015 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that Jim Kelly, Vanda's Senior Vice President and Chief Financial Officer, will deliver a corporate presentation at the Canaccord Genuity Annual Growth Conference in Boston, Massachusetts on Wednesday, August 12, 2015 at 1:30 p.m. Eastern Time.

The presentation at the Canaccord Genuity Annual Growth Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days.  To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page.  Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Company Contact: Jim Kelly Senior Vice President and Chief Financial Officer Vanda Pharmaceuticals Inc. (202) 734-3428 jim.kelly@vandapharma.com

SOURCE Vanda Pharmaceuticals Inc.



RELATED LINKS

http://www.vandapharma.com